Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-247
Semaglutide
Cat. No.
AKA-247
CAS No.
910463-68-2
MF
C142H216N38O45
MW
3175.47
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Semaglutide
CAS No.
910463-68-2
MF
C142H216N38O45
MW
3175.47
Specification
医药级
Research Area
Treats type 2 diabetes and obesity by improving blood sugar.
Description
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Packing: 1 kg (net) PE bags; 5kg (net) PE bags Availability: For Compounding pharmacy under FD&C Act 503A or 503B only
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Chang YF, et al. Semaglutide-mediated protection against Aβ correlated with enhancement of autophagy and inhibition of apoptosis. Journal of Clinical Neuroscience. 2020 Nov;81:234-239.
[2]. Liu DX, et al. Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress. Parkinson's Disease. 2022 Jul 13;2022:6813017.
[3]. Zhang L, et al. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease. Journal of Parkinson's Disease. 2019;9(1):157-171.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
